GB001 in Adult Participants With Chronic Rhinosinusitis

Clinical trial NCT03956862 · COMPLETED

Trial details

NCT number: NCT03956862
Sponsor: GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Start date: 2019-05-16
Primary completion: 2020-07-09
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.